Subscribe to RSS
DOI: 10.1055/s-2008-1004621
© Georg Thieme Verlag Stuttgart · New York
PET / CT-basierte Bestrahlungsplanung bei Patienten mit Kopf-Hals-Tumoren
PET / CT Based Radiotherapy Planning in Patients with Head and Neck CancerPublication History
Publication Date:
28 February 2008 (online)
![](https://www.thieme-connect.de/media/nuklmed/200801/lookinside/thumbnails/10.1055-s-2008-1004621-1.jpg)
Zusammenfassung
Die PET / CT mit FDG und Kontrastmittel wird sowohl in der Strahlentherapieplanung und zum Monitoring während der Therapie, als auch zur Verlaufskontrolle nach Therapieende bei Patienten mit Kopf-Hals-Tumoren zunehmend eingesetzt. Ziel dieses Artikels ist die Darstellung des aktuellen Stellenwertes der PET / CT für Patienten mit Tumoren des Kopf-Hals-Bereiches, die sich einer primären, kurativen Strahlentherapie unterziehen müssen.
Abstract
PET / CT with FDG and contrast medium is used in planning, monitoring and follow-up in patients with head and neck cancer. The aim of this article is to demonstrate the current role of PET / CT for patients with head and neck cancer undergoing a primary curative radiotherapy.
Schlüsselwörter
PET / CT - FDG - Strahlentherapie - Bestrahlungsplanung - Kopf-Hals-Tumoren
Key words
PET / CT - FDG - radiotherapy - radiotherapy planning - head and neck cancer
Literatur
- 1 Adams S, Baum R P, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998; 25 1255-1260
- 2 Andrade R S, Heron D E, Degirmenci B. et al . Posttreatment assessment of response using FDG-PET / CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006; 65 1315-1322
- 3 Appold S, Herrmann T, Baumann M. Feasibility of high-dose hyperfractionated re-irradiation in patients with recurrent or second head and neck tumors. Radiother Oncol. 2007; 82 19
- 4 Benchaou M, Lehmann W, Slosman D O. et al . The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol. 1996; 116 332-335
- 5 Caulk R M. Head and neck cancer from the standpoint of a clinical radiotherapist. J Iowa State Med Soc. 1958; 48 493-495
- 6 Daisne J F, Duprez T, Weynand B. et al . Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG-PET and validation with surgical specimen. Radiology. 2004; 233 93-100
- 7 Ford E C, Kinahan P E, Hanlon L. et al . Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. Med Phys. 2006; 33 4280-4288
- 8 Freudenberg L S, Fischer M, Antoch G. et al . Dual modality of 18F-fluorodeoxyglucose-positron emission tomography / computed tomography in patients with cervical carcinoma of unknown primary. Med Princ Pract. 2005; 14 155-160
- 9 Geets X, Lee J A, Bol A, Lonneux M, Gregoire V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging. 2007; 34 1427-1438
- 10 Gregoire V, Bol A, Geets X, Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol. 2006; 16 232-238
- 11 Haberkorn U, Strauss L G, Dimitrakopoulou A. et al . Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med. 1993; 34 12-17
- 12 Krause B J, Beyer T, Bockisch A, Delbeke D, Kotzerke J, Minkov V, Reiser M, Willich N. FDG-PET / CT in oncology - German guideline. Nuklearmedizin. 2007; 46 , DOI: 10.3413/nukmed-0282 [epub ahead of print]
- 13 Madani I, Duthoy W, Derie C. et al . Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2007; 68 126-135
- 14 McGuirt W F, Williams 3rd D W, Keyes Jr J W. et al . A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope. 1995; 105 373-375
- 15 Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose. J Nucl Med. 1988; 29 1521-1525
- 16 Reske S N, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, “Onko-PET III”, 21 July and 19 September 2000. Eur J Nucl Med. 2001; 28 1707-1723
- 17 Riegel A C, Berson A M, Destian S. et al . Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET / CT fusion. Int J Radiat Oncol Biol Phys. 2006; 65 726-732
- 18 Schwartz D L, Ford E, Rajendran J. et al . FDG-PET / CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005; 61 129-136
- 19 Steenbakkers R J, Duppen J C, Fitton I. et al . Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a ‘Big Brother’ evaluation. Radiother Oncol. 2005; 77 182-190
- 20 Teknos T N, Rosenthal E L, Lee D, Taylor R, Marn C S. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck. 2001; 23 1056-1060
- 21 Wang D, Schultz C J, Jursinic P A. et al . Initial experience of FDG-PET / CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006; 65 143-151
- 22 Yen R F, Chen T H, Ting L L, Tzen K Y, Pan M H, Hong R L. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2005; 32 1152-1159
- 23 Zimmer L A, Snyderman C, Fukui M B. et al . The use of combined PET / CT for localizing recurrent head and neck cancer: the Pittsburgh experience. Ear Nose Throat J. 2005; 84 104 106 108-110
PD Dr. N. Abolmaali
OncoRay - Zentrum für Innovationskompetenz Strahlenforschung in der Onkologie, Biologisches und Molekulares Imaging · Medizinische Fakultät · Universitätsklinikum Carl Gustav Carus · TU Dresden
Haus 31, Pf 86
Fetscherstr. 74
01307 Dresden
Email: Nasreddin.Abolmaali@OncoRay.de